Foreman R D, Linderoth B, Ardell J L, Barron K W, Chandler M J, Hull S S, TerHorst G J, DeJongste M J, Armour J A
Department of Physiology, OUHSC, Oklahoma City, OK 73190, USA.
Cardiovasc Res. 2000 Aug;47(2):367-75. doi: 10.1016/s0008-6363(00)00095-x.
Electrical stimulation of the dorsal aspect of the upper thoracic spinal cord is used increasingly to treat patients with severe angina pectoris refractory to conventional therapeutic strategies. Clinical studies show that spinal cord stimulation (SCS) is a safe adjunct therapy for cardiac patients, producing anti-anginal as well as anti-ischemic effects. However, little information is yet available about the underlying mechanisms involved.
In order to determine its mechanism of action, the effects of SCS on the final common integrator of cardiac function, the intrinsic cardiac nervous system, was studied during basal states as well as during transient (2 min) myocardial ischemia. Activity generated by intrinsic cardiac neurons was recorded in 9 anesthetized dogs in the absence and presence of myocardial ischemia before, during and after stimulating the dorsal T1-T2 segments of the spinal cord at 66 and 90% of motor threshold using epidural bipolar electrodes (50 Hz; 0.2 ms; parameters within the therapeutic range used in humans).
The SCS suppressed activity generated by intrinsic cardiac neurons. No concomitant change in monitored cardiovascular indices was detected. Neuronal activity increased during transient ventricular ischemia (46%), as well as during the early reperfusion period (68% compared to control). Despite that, activity was suppressed during both states by SCS.
SCS modifies the capacity of intrinsic cardiac neurons to generate activity. SCS also acts to suppress the excitatory effects that local myocardial ischemia exerts on such neurons. Since no significant changes in monitored cardiovascular indices were observed during SCS, it is concluded that modulation of the intrinsic cardiac nervous system might contribute to the therapeutic effects of SCS in patients with angina pectoris.
上胸段脊髓背侧的电刺激越来越多地用于治疗对传统治疗策略难治的严重心绞痛患者。临床研究表明,脊髓刺激(SCS)是心脏病患者的一种安全辅助治疗方法,可产生抗心绞痛和抗缺血作用。然而,关于其潜在机制的信息仍然很少。
为了确定其作用机制,在基础状态以及短暂(2分钟)心肌缺血期间,研究了SCS对心脏功能的最终共同整合器——心脏固有神经系统的影响。使用硬膜外双极电极(50Hz;0.2ms;参数在人类使用的治疗范围内),以运动阈值的66%和90%刺激脊髓的T1-T2背段之前、期间和之后,在9只麻醉犬中记录心脏固有神经元产生的活动,记录有无心肌缺血的情况。
SCS抑制了心脏固有神经元产生的活动。未检测到监测的心血管指标有伴随变化。在短暂性心室缺血期间(46%)以及早期再灌注期间(与对照组相比为68%),神经元活动增加。尽管如此,在这两种状态下SCS均抑制了活动。
SCS改变了心脏固有神经元产生活动的能力。SCS还起到抑制局部心肌缺血对此类神经元产生的兴奋作用。由于在SCS期间未观察到监测的心血管指标有显著变化,因此得出结论,心脏固有神经系统的调节可能有助于SCS对心绞痛患者的治疗效果。